South Korea HLA Typing Market (2025-2030)
The South Korea HLA Typing Market was valued at $7.5 Million in 2025 and projected to reach to $8.4 Million by 2030, representing a compound annual growth rate of 2.2%. South Korea's HLA typing market demonstrates steady growth driven by the country's advanced healthcare infrastructure and increasing prevalence of organ transplantation procedures.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea HLA Typing Market Trends and Insights
- This modest but steady growth reflects South Korea's advanced healthcare infrastructure and increasing demand for organ transplantation and immunological diagnostics.
- South Korea's investment in precision medicine and transplant programs continues to drive adoption of HLA typing technologies across major medical centers and diagnostic laboratories. The South Korea HLA typing market benefits from the country's aging population and rising prevalence of organ failure conditions requiring transplantation.
- South Korea's regulatory environment and reimbursement policies support the integration of HLA typing into clinical workflows, particularly for kidney, liver, and heart transplants.
- Between 2025 and 2030, South Korea is expected to see incremental growth driven by technological improvements in typing methodologies and expanded access to testing in secondary healthcare facilities..
Key Market Statistics
- CAGR (2025-2030) 2.2% CAGR
- Market Size, 2025 ~USD 7.5 Million
- Forecast, 2030 ~USD 8.4 Million
- Country South Korea
South Korea HLA Typing Market Overview
Market Valuation :
South Korea's HLA typing market is valued at $7.5 million in 2025, with steady growth projected to reach $8.4 million by 2030, representing a CAGR of 2.2%.
Advanced Healthcare Infrastructure :
South Korea's sophisticated healthcare system and high adoption of precision medicine technologies drive consistent demand for HLA typing services in transplantation and immunological diagnostics.
Transplant Program Growth :
Increasing organ transplantation procedures and immunological testing requirements in South Korea's leading medical centers support steady market expansion and clinical adoption.
Precision Medicine Investment :
South Korea's strategic focus on precision medicine and personalized healthcare solutions creates sustained demand for HLA typing in both clinical and research applications.
South Korea HLA Typing Market Dynamics
- The market's modest 2.2% CAGR reflects a mature healthcare landscape with established clinical protocols and consistent demand for immunological diagnostics.
- South Korea's investment in precision medicine initiatives and transplant program expansion supports continued market development through 2030. The market outlook remains positive as South Korea continues to enhance its transplant capabilities and integrate HLA typing into broader immunological testing frameworks.
- Growing awareness of personalized medicine and improved reimbursement policies for transplant-related diagnostics are expected to sustain market growth.
- Strategic partnerships between diagnostic laboratories and transplant centers will further strengthen market penetration across South Korea's healthcare system..
Related Ecosystem
Key Takeaways
- South Korea's HLA typing market is valued at $7.5 million in 2025 with a projected value of $8.4 million by 2030.
- South Korea experiences a 2.2% CAGR, reflecting steady but moderate growth compared to global expansion rates.
- South Korea's advanced healthcare system and transplant infrastructure support consistent demand for HLA typing services.
- South Korea's aging population and organ failure prevalence drive long-term market expansion through 2030.
HLA Typing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | COMMERCIAL SERVICE PROVIDERS (End User) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6% from 2025 to 2030 |
| Largest Segment | DIAGNOSTIC APPLICATIONS (Application) |
| Market Size Base Year (Billions) | ~USD 1.72 (2025) |
| Revenue Forecast (Billions) | ~USD 2.3 (2030) |
| Segments Covered | Product & Service, Technology, Type, Application, End User, Diagnostic Application |
South Korea HLA Typing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents & Consumables
- Software & Services
By Technology
- Molecular Assay Technologies
- Non-Molecular Assay Technologies
By Type
- Cancer Diagnosis & Prevention
- Donor-Recipient Cross-Matching
- Infectious Disease Testing
- Next-Generation Sequencing
- Other Diagnostic Applications
- Other Pcr-Based Molecular Assays
- Other Sequencing-Based Molecular Assays
- Pcr-Based Molecular Assays
- Real-Time Pcr
- Sanger Sequencing
- Sequence-Specific Oligonucleotide-Pcr
- Sequence-Specific Primar-Pcr
- Sequence-Specific Primer-Pcr
- Sequencing-Based Molecular Assays
- Transfusion Therapy
By Application
- Diagnostic Applications
- Research Applications
By End User
- Commercial Service Providers
- Hospitals & Transplant Centers
- Research Laboratories & Academic Institutes
By Diagnostic Application
- Cancer Diagnosis & Prevention
- Donor-Recipient Cross-Matching
- Infectious Disease Testing
- Other Diagnostic Applications
- Transfusion Therapy
Target Audience
- Diagnostic Laboratory Operators : South Korea-based and international diagnostic labs need market sizing and growth forecasts to plan HLA typing service expansion, equipment investment, and staffing decisions in this steady-growth market.
- Medical Device Manufacturers : HLA typing equipment and reagent manufacturers require South Korea-specific market data to assess market potential, competitive positioning, and distribution strategy in this advanced healthcare market.
- Transplant Center Administrators : Hospital transplant programs and immunology departments need market insights to justify HLA typing infrastructure investments and understand clinical demand trends across South Korea.
- Healthcare Investors & Consultants : Investment firms and management consultants evaluating South Korea's healthcare diagnostics sector need precise market data and growth projections for portfolio decisions and strategic recommendations.
- Precision Medicine Companies : Personalized medicine and genomics firms expanding into South Korea require market intelligence on HLA typing adoption, clinical integration opportunities, and precision healthcare trends.
Key Companies in the South Korea HLA Typing Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BGI GENOMICS | China | Public Company | Sequencing-based HLA services (NGS, immune repertoire, WES/WGS-derived typing),Reagents & consumables for HLA workflows,Instruments (sequencers and related hardware used for HLA), |
| BECTON DICKINSON AND CO | United States | Public Company | Instruments,Reagents,Software, |
| BD | United States | Public Company | Instruments,Reagents,Software, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Sequencing-based HLA (NGS, Sanger),PCR-based HLA (SSO, SSP, Real-time),Software and Informatics, |
| ILLUMINA, INC. | United States | Public Company | Sequencing Instruments (NGS platforms used for HLA typing),Sequencing Reagents, Flow Cells, and Library Prep for HLA,Software and DRAGEN-based Secondary Analysis for HLA, |
| QIAGEN | Netherlands | Public Company | Reagents & Consumables (PCR, NGS, sample technologies for HLA workflows),Instruments (PCR, NGS-related, automation, QC),Software & Bioinformatics (HLA analysis, SaaS, interpretation), |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Reagents & Consumables (PCR and sequencing HLA kits),Instruments (PCR, sequencing-adjacent, and automation),Software & Informatics (HLA analysis, LIS connectivity), |
| F. HOFFMANN-LA ROCHE LTD | United States | ||
| CAREDX, INC. | United States | Public Company | HLA Typing Reagents & Assays (PCR SSO/SSP, Real-time, NGS, Sanger),Instruments & NGS Workflow Components,Software (Ottr, HLA Data Systems, XynQAPI, MedActionPlan, others), |
| DIASORIN S.P.A. | Italy | Public Company | Instruments,Reagents,Software, |
| EUROBIO SCIENTIFIC | France | Public Company | Reagents (PCR and NGS HLA typing),Software (HLA typing analysis and reporting),Instruments (sequencers, ancillary lab systems), |
BGI GENOMICS
BGI Genomics is a Chinese public company founded in 1999 that employs 3,580 people. The company operates in the genomics and genetic sequencing sector.
BECTON DICKINSON AND CO
Becton Dickinson and Co is a United States-based public company founded in 1897 with 72,000 employees. The company operates in the medical devices and diagnostics sector.
BD
BD is a United States-based public company founded in 1897 with 72,000 employees. The company operates in the medical devices and diagnostics sector.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company operates in the life sciences and diagnostics industry.
ILLUMINA, INC.
Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. The company specializes in DNA sequencing and genetic analysis technologies.
QIAGEN
QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees. The company operates in the molecular diagnostics and life sciences sector.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. The company manufactures and distributes life science research and clinical diagnostics products.
F. HOFFMANN-LA ROCHE LTD
Insufficient data available to provide a business description for this company.
CAREDX, INC.
CareDx, Inc. is a United States-based public company founded in 1998 with 763 employees. The company operates in the molecular diagnostics and transplant monitoring sector.
DIASORIN S.P.A.
DiaSorin S.p.A. is an Italy-based public company founded in 1968 with 3,242 employees. The company specializes in diagnostic solutions and immunoassay products.
EUROBIO SCIENTIFIC
Eurobio Scientific is a France-based public company founded in 1997 with 343 employees. The company operates in the life sciences and diagnostics industry.
Reasons to Buy this Report
- Market-Specific Sizing Data : Access precise valuation figures for South Korea's HLA typing market ($7.5M in 2025) with detailed 5-year forecasts enabling accurate budget allocation and investment planning.
- Competitive Landscape Intelligence : Understand South Korea's unique market dynamics, key players, and clinical adoption patterns specific to the country's advanced healthcare infrastructure and transplant programs.
- Growth Driver Analysis : Identify South Korea-specific factors driving the 2.2% CAGR, including precision medicine initiatives, transplant program expansion, and reimbursement policy developments.
- Strategic Market Entry Guidance : Develop targeted go-to-market strategies for South Korea with insights into regulatory requirements, healthcare provider preferences, and clinical adoption barriers specific to the region.
- Investment Decision Support : Make informed investment and partnership decisions with comprehensive South Korea market data, growth projections, and opportunity assessment through 2030.
Frequently asked questions
What is the current size of South Korea's HLA typing market?
South Korea's HLA typing market is estimated at $7.5 million in 2025, based on verified market data.
What is the projected market size for South Korea by 2030?
South Korea's HLA typing market is forecast to reach $8.4 million by 2030, representing growth from the 2025 baseline.
What is the growth rate for South Korea's HLA typing market?
South Korea's HLA typing market is expected to grow at a compound annual growth rate of 2.2% between 2025 and 2030.
Why is South Korea's HLA typing market growing?
South Korea's market growth is driven by an aging population, increased organ transplantation demand, and advanced healthcare infrastructure supporting precision medicine adoption.
How does South Korea's HLA typing market compare to global trends?
South Korea's 2.2% CAGR is lower than the global 6% CAGR, reflecting a more mature and stable market with established transplant programs.
RESEARCH METHODOLOGY
This research study extensively utilized secondary sources, directories, and databases to identify and gather valuable information for analyzing the global HLA typing market. Additionally, in-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives from leading market players, and industry consultants. These interviews helped obtain and validate critical qualitative and quantitative data while assessing the growth prospects. The global market size, initially estimated through secondary research, was then refined and finalized through triangulation with insights from primary research.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the HLA typing market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various companies and organizations in the HLA typing market. The primary sources from the demand side include OEMs, private and contract testing organizations, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The bottom-up approach was used to estimate and validate the total size of the HLA typing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- A list of the major global players operating in the HLA typing market was generated.
- Mapping annual revenues generated by major global players from the HLA typing segment (or nearest reported business unit/service category)
- Revenue mapping of key players to cover a major share of the global market as of 2024
- Extrapolating the global value of the HLA Typing industry
Global HLA Typing Market Size: Bottom-up Approach and Top-down Approach
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
HLA typing is a genetic procedure to determine donor-recipient compatibility, cancer & autoimmune disorder diagnosis, pathogen testing, and transfusion therapy. Additionally, it is used in drug testing, disputed paternity, and anthropological studies. Advanced genomic techniques, such as PCR and NGS, are increasingly being used in HLA typing, apart from serological and other conventional techniques for immuno-compatibility testing.
Stakeholders
- HLA Typing Product Manufacturers
- Healthcare Service Providers (Hospitals, Transplant Centers, and Blood Transfusion Centers)
- Blood, Tissue, and Stem Cell Banks
- Government Organizations
- Independent Associations and Regulatory Authorities
- R&D Companies
- Independent Reference Laboratories
- Diagnostic Laboratories
- Clinical Research Organizations
- Research Laboratories and Academic Institutes
Report Objectives
- To define, describe, and forecast the HLA typing market based on technology, product & service, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global HLA typing market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micro markets with respect to individual growth trends, future prospects, and contributions to the global HLA typing market
- To analyze key growth opportunities in the global HLA typing market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa (GCC Countries and Rest of Middle East & Africa)
- To profile the key players in the HLA typing market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global HLA typing market, such as agreements, expansions, and acquisitions
Get the Full HLA Typing Market Report
Full forecast, segment splits, and company analysis for all HLA Typing Market.
- Canada HLA Typing Market
- US HLA Typing Market
- Germany HLA Typing Market
- UK HLA Typing Market
- France HLA Typing Market
- Spain HLA Typing Market
- Italy HLA Typing Market
- China HLA Typing Market
- Japan HLA Typing Market
- India HLA Typing Market
- Australia HLA Typing Market
- Brazil HLA Typing Market
- Mexico HLA Typing Market
- Rest Of Europe HLA Typing Market
- Rest Of Asia HLA Typing Market
- Rest Of Latin America HLA Typing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
